πŸ‡ΊπŸ‡Έ FDA
Patent

US 7919485

Protein kinase targeted therapeutics

granted A61KA61K31/50A61K45/06

Quick answer

US patent 7919485 (Protein kinase targeted therapeutics) held by Northwestern University expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/50, A61K45/06, A61P, A61P29/00